EYA1

From WikiMD's WELLNESSPEDIA

EYA1 is a gene that encodes a protein known as Eyes Absent Homolog 1. This protein plays a crucial role in organ development and maintenance, particularly in the eye, ear, and kidney. Mutations in the EYA1 gene can lead to several genetic disorders, including Branchiootorenal syndrome and Otofaciocervical syndrome.

Function[edit]

The EYA1 gene provides instructions for making a protein that is involved in the formation of several types of tissue, including tissues in the eyes, ears, and kidneys. This protein is a part of a group of proteins that work together to control the development of these organs. The EYA1 protein also interacts with other proteins to control the activity of certain genes during the early stages of development.

Genetic Disorders[edit]

Mutations in the EYA1 gene can lead to several genetic disorders. These include:

  • Branchiootorenal syndrome: This is a condition that disrupts the development of tissues in the neck and causes malformations of the ears and kidneys. People with this condition often have hearing loss and kidney abnormalities.
  • Otofaciocervical syndrome: This is a condition characterized by a wide range of features, including facial abnormalities, hearing loss, and skeletal abnormalities of the neck and shoulders.

Diagnosis and Treatment[edit]

Diagnosis of disorders related to the EYA1 gene typically involves genetic testing to identify mutations in the EYA1 gene. Treatment options vary depending on the specific disorder and its symptoms, but may include surgery, hearing aids, and kidney transplantation.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.